Information  X 
Enter a valid email address

Powderject Pharm (PJP)

  Print      Mail a friend

Monday 10 June, 2002

Powderject Pharm

Director Shareholding

Powderject Pharmaceuticals PLC
10 June 2002


                       DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

    POWDERJECT PHARMACEUTICALS PLC

2)  NAME OF DIRECTOR

    Dr PAUL DRAYSON

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

    AS IN 2 ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

    Dr PAUL DRAYSON

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)



6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary



7)  Number of shares/amount of
    stock acquired



8)   (N/A %)
    of issued Class



9)  Number of shares/amount
    of stock disposed

    33,000

10)  ( 0.0362%)
    of issued Class



11) Class of security



12) Price per share



13) Date of transaction

    31 MAY 2002

14) Date company informed

    10 JUNE 2002

15) Total holding following this notification

    7,164,213

16) Total percentage holding of issued class following this notification

    7.866%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information



24) Name of contact and telephone number for queries

    ZOE EVANS  
    01865 782867

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification    10 JUNE 2002                             



                      This information is provided by RNS
            The company news service from the London Stock Exchange